drugset / Trial / NCT01061320

Efficacy of Alpha Tocopherol for Prevention of Contrast-induced Nephropathy in Chronic Kidney Disease (CKD) Patients

NCT01061320

Phase 3 Unknown 200 enrolled Thammasat University
RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to demonstrate the efficacy of alpha tocopherol for prevention contrast-induced nephropathy in CKD patients undergoing elective coronary procedures.

Timeline

Start
2010-01
Primary completion
2010-10
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator alpha-tocopherol Unknown 525 iu Oral